Software Engineer, Virta Health

Instead of depending upon medication, which often needs to be increased over time, the company is tackling the problem at its root and taking a fundamentally different approach that is better for the patient, and more economical for insurers. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal.

While other platforms serve similar markets, the large number of prediabetic and diabetic Americans presents a significant opportunity for growth. The company is well-funded and continues to expand the reach of its telehealth-powered diabetes reversal treatment - positioning itself for widespread adoption as it addressies this critical healthcare challenge.